ChartRow logo
ChartRow
Investing Charts
GILD
Gilead Sciences Inc.Stock · HealthcareNasdaq-100 1.0% · S&P 500 0.3%
$129.31−$1.55 (-1.18%)as of market close, Jul 24, 2026
CompareLLYUNHJNJABBVISRGABT

GILDGilead Sciences Inc. stock price, chart and key statistics

Key stats

Price data

Price
$129.31
Change YTD
+6.34%
Next earnings
Aug 4, 2026 · After close
Market cap
160.5B
Enterprise value
173.8B
Shares outstanding
1.2B
52W low
$108.46
52W high
$157.29
From 52W high
-17.79%
From 52W low
+19.22%
52W range
43%
Beta
0.34

Volume

Rel volume
1.12×
30D volume
7.6M
30D $ vol
976.5M

Fundamentals

Sales (ttm)
29.7B
Sales/share
$23.95
EPS (ttm)
$7.35
FCF (ttm)
10.2B
FCF/share
$8.24
Book value/share
$18.94
Net margin
30.99%
ROE
39.19%
ROA
16.38%
Debt / equity
0.89×
Current ratio
1.97

Growth (CAGR, ttm) · 10Y

Sales
-0.99%
Net income
-6.13%
FCF
-5.94%
Shares
-0.70%

Per-share growth (CAGR, ttm) · 10Y

EPS
-4.54%
Sales/share
-0.29%
FCF/share
-5.28%
Book value/share
+6.53%
Dividend/share
+6.37%
Price
+4.09%
Total return
+7.74%

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)
17.4×
Fwd P/E
13.5×
P/S (ttm)
5.4×
P/B (mrq)
6.8×
P/FCF (ttm)
15.7×
EV/EBITDA (fy)
16.7×
EV/Sales (ttm)
5.8×
FCF yield (ttm)
6.37%
Dividend yield (fwd)
2.54%
Dividend/share (fwd)
$3.28
Buyback yield (ttm)
0.80%
Shareholder yield (ttm)
3.31%

Vs own 10Y history

P/E
41st
P/S
96th
P/B
88th
P/FCF
93rd

Bar = where today's multiple sits in GILD's own 10-year range:near a decade-low (cheap)near a decade-high (rich).

Performance

1D
-1.18%
1W
-3.70%
1M
+3.32%
3M
-3.24%
YTD
+6.34%
1Y
+13.87%
5Y
+88.42%

Financial statements

Open full GILD financials →

Related Healthcare

1M
TickerThemePrice1M30D $Vol
LLY
Eli Lilly and Company
Pharmaceuticals$1,196+7.05%3.2B
JNJ
Johnson & Johnson
Pharmaceuticals$263+9.30%2.1B
ABBV
AbbVie Inc.
Biopharma$259+10.36%1.9B
UNH
UnitedHealth Group Incorporated Common Stock (DE)
$421+3.66%2.6B
MRK
Merck & Co. Inc.
Pharmaceuticals$131+8.70%1.3B
TMO
Thermo Fisher Scientific Inc.
Life Sciences$568+15.45%1.1B
AMGN
Amgen Inc.
Biotech$376+7.00%969.4M
ABT
Abbott Laboratories
Medical Devices$103+13.95%1.3B

Gilead Sciences Inc. (GILD) trades at $129.31 with a live price and an interactive chart covering 34+ years of daily price history, plus key valuation metrics. ChartRow also publishes GILD's financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full GILD financial statements →